These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21029061)

  • 21. [Cerebral white matter lesions in the elderly: vascular risk factors and cognitive consequences].
    de Leeuw FE; de Groot JC; van Gijn J
    Ned Tijdschr Geneeskd; 2001 Oct; 145(43):2067-71. PubMed ID: 11715591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
    Rosich-Estragó M; Figuera-Terré L; Mulet-Pérez B; Arrufat-Cardús MT; Pascual San Emeterio A; Arbeola-Rigau I; Labad-Alquézar A; Vilella-Cuadrada E
    Rev Neurol; 2004 May 1-15; 38(9):801-7. PubMed ID: 15152345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive decline and dementia related to cerebrovascular diseases: some evidence and concepts.
    Pantoni L; Poggesi A; Inzitari D
    Cerebrovasc Dis; 2009; 27 Suppl 1():191-6. PubMed ID: 19342851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cognitive reserve and neural networks in normal aging and Alzheimer's disease].
    Kalpouzos G; Eustache F; Desgranges B
    Psychol Neuropsychiatr Vieil; 2008 Jun; 6(2):97-105. PubMed ID: 18556268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Some developments in brain ageing and dementia.
    Perry E; Kay DW
    Br J Biomed Sci; 1997 Sep; 54(3):201-15. PubMed ID: 9499598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subcortical ischemic cerebrovascular dementia.
    Menon U; Kelley RE
    Int Rev Neurobiol; 2009; 84():21-33. PubMed ID: 19501711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Terminal cognitive decline: accelerated loss of cognition in the last years of life.
    Wilson RS; Beck TL; Bienias JL; Bennett DA
    Psychosom Med; 2007; 69(2):131-7. PubMed ID: 17327212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRI identifies MCI subtypes: vascular versus neurodegenerative.
    Meyer JS; Quach M; Thornby J; Chowdhury M; Huang J
    J Neurol Sci; 2005 Mar; 229-230():121-9. PubMed ID: 15760630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease.
    Frisardi V; Solfrizzi V; Seripa D; Capurso C; Santamato A; Sancarlo D; Vendemiale G; Pilotto A; Panza F
    Ageing Res Rev; 2010 Oct; 9(4):399-417. PubMed ID: 20444434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Social and biological determinants of cognitive aging.
    Brunner EJ
    Neurobiol Aging; 2005 Dec; 26 Suppl 1():17-20. PubMed ID: 16257477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normal cognitive decline or dementia?
    Ebmeier KP
    Practitioner; 2010 Jan; 254(1725):23-7, 2-3. PubMed ID: 20198932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular risk factors and dementia.
    Fillit H; Nash DT; Rundek T; Zuckerman A
    Am J Geriatr Pharmacother; 2008 Jun; 6(2):100-18. PubMed ID: 18675769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive reserve and the neurobiology of cognitive aging.
    Whalley LJ; Deary IJ; Appleton CL; Starr JM
    Ageing Res Rev; 2004 Nov; 3(4):369-82. PubMed ID: 15541707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Vascular risk factors and cognitive change in the elderly].
    Fernández García C; Bermejo Pareja F; Gabriel Sánchez R
    Rev Clin Esp; 1999 Jul; 199(7):456-64. PubMed ID: 10481563
    [No Abstract]   [Full Text] [Related]  

  • 35. Potential for antihypertensive treatment with an AT(1)-receptor blocker to reduce dementia in the elderly.
    Trenkwalder P
    J Hum Hypertens; 2002 Aug; 16 Suppl 3():S71-5. PubMed ID: 12140732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Theory of Mind in normal ageing and neurodegenerative pathologies.
    Kemp J; Després O; Sellal F; Dufour A
    Ageing Res Rev; 2012 Apr; 11(2):199-219. PubMed ID: 22186031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroangiogenesis: a vascular basis for Alzheimer's disease and cognitive decline during aging.
    Ambrose CT
    J Alzheimers Dis; 2012; 32(3):773-88. PubMed ID: 22850316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Healthy brain aging: a road map.
    Desai AK; Grossberg GT; Chibnall JT
    Clin Geriatr Med; 2010 Feb; 26(1):1-16. PubMed ID: 20176289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lifestyle and health-related risk factors and risk of cognitive aging among older veterans.
    Yaffe K; Hoang TD; Byers AL; Barnes DE; Friedl KE
    Alzheimers Dement; 2014 Jun; 10(3 Suppl):S111-21. PubMed ID: 24924664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Normal aging and cognition: the unacknowledged contribution of cerebrovascular risk factors.
    Morra L; Zade D; McGlinchey RE; Milberg WP
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2013; 20(3):271-97. PubMed ID: 22708889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.